Physician profile
Jonathan Marinaro
NPI 1356358311
$8,016.10
in general payments reported to CMS, 2019-2025
11 companies · $261 in 2025
The $261 reported for 2025 was more than what 87% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $198 · 2022: $754 · 2023: $6,261 · 2024: $317 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,500 · Food and Beverage: $1,339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,500.00 |
| Food and Beverage | $1,338.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ceribell, INC. | $5,500.00 | 2023 | Ceribell Rapid Response Eeg |
| Inari Medical, INC. | $1,243.72 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $465.85 | 2020-2024 | Impella |
| Stryker Corporation | $261.21 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Edwards Lifesciences Corporation | $119.75 | 2019 | |
| Abbott Laboratories | $111.55 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Teleflex LLC | $108.88 | 2022 | |
| Haemonetics Corporation | $72.73 | 2022 | |
| Getinge USA Sales, LLC | $59.80 | 2019 | |
| Nxstage Medical, INC. | $46.60 | 2019 | |
| Livanova USA, INC. | $26.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Marinaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.